Acta neurochirurgica
September 15, 2026 · via Europe PMC
Longitudinal changes in pain catastrophizing and multidimensional health outcomes after passive-recharge burst spinal cord stimulation: a cohort study with follow-up to two years.
Wänman J, Östman J, Tabatabaei P.
AI summary — for doctors, generated from the abstract only
In a retrospective cohort of 58 patients undergoing spinal cord stimulation, pain catastrophizing scores decreased substantially and persisted for up to 2 years, but baseline catastrophizing did not predict subsequent pain relief or most patient-reported outcomes.
What was studied
A retrospective cohort study using prospectively collected data from 58 patients undergoing passive-recharge burst spinal cord stimulation (SCS) implantation, measuring the Pain Catastrophizing Scale (PCS) at baseline and 3, 6, 12, and 24 months, alongside pain intensity (NRS) and PROMIS-29 multidimensional health outcomes; PCS analyses were restricted to the 38 patients with available baseline data.
Key findings
- Among the 38 patients with baseline PCS data, mean PCS scores decreased from 24 +/- 12 at baseline to 14.0 +/- 11 at 24 months (the exact p-value is cut off in the available abstract text, but the change is described as significant).
- Baseline PCS was not significantly associated with subsequent pain response or most other patient-reported outcomes.
- The authors suggest PCS may represent a dynamic outcome measure that complements conventional pain-intensity assessment over time.
Clinical relevance
The findings suggest that pain catastrophizing may improve meaningfully and durably after SCS implantation and could be tracked as an outcome alongside pain intensity, though baseline catastrophizing does not appear to reliably predict who will benefit, based on this observational cohort.
Who should care
Limitations
This was a retrospective cohort without a control group, and PCS analyses were limited to a subset of 38 of the 58 total patients who had baseline data available.
Pain catastrophizing scores improved and stayed lower for up to 2 years after spinal cord stimulation, though baseline catastrophizing did not predict which patients would benefit.
This is an AI-generated summary of the published abstract, not a clinical recommendation. It may not reflect the full text or subsequent updates — verify against the original source before acting on it.
Abstract
Purpose
To evaluate longitudinal changes in pain catastrophizing following spinal cord stimulation (SCS) and to determine whether baseline pain catastrophizing was associated with patient-reported outcomes over two years after implantation.
Methods
A retrospective cohort study using prospectively collected data from 58 patients undergoing SCS implantation. Pain catastrophizing was assessed using the Pain Catastrophizing Scale (PCS), and pain intensity and multidimensional health outcomes were assessed using the Numeric Rating Scale (NRS) and PROMIS-29, respectively. The primary outcome was change in PCS from baseline. Analyses of PCS were restricted to patients with available baseline PCS data (n = 38). PCS was assessed at baseline and at 3, 6, 12, and 24 months after SCS implantation. Changes from baseline were evaluated using paired t-tests. Associations between baseline PCS and post-implant outcomes were assessed using Spearmans rank correlation.
Results
Among the 38 patients with baseline PCS data, mean PCS scores decreased from 24 ± 12 at baseline to 14.0 ± 11 at 24 months (p < 0.001), with reductions across all three PCS subgroups. Physical function, pain interference, pain intensity, fatigue, anxiety, depression, and participation in social roles also improved significantly during follow-up, whereas sleep disturbance showed no significant change. Baseline PCS was not correlated with most post-implant PROMIS-29 domains.
Conclusion
PCS decreased substantially and persistently following SCS implantation among patients with available baseline PCS data. Baseline PCS was not significantly associated with subsequent pain response or most patient-reported outcomes. PCS may represent a dynamic outcome measure that complements conventional pain-intensity assessment.
DOI
10.1007/s00701-026-07033-9
PMID
42747509
PMCID
PMC13582312
Research metadata (titles, abstracts, authors, publication dates) is sourced from Europe PMC, which aggregates content from PubMed/MEDLINE, PubMed Central, and other providers under the U.S. National Library of Medicine (NLM/NCBI). NLM does not claim copyright on abstracts; the original journal publishers or authors may hold rights to the full articles. AI-generated summaries are derived only from the abstract, never the full text, and are always labeled as AI-generated.
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
Back to the research feed